MktsMarkets

Amphastar Pharmaceuticals, Inc.
NASDAQ: AMPHKey statistics
AMPH News
Stories mentioning AMPH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 171,171 | 183,105 | 191,840 | 174,414 | 170,528 | 186,523 | 191,214 | 182,394 |
| Cost of Goods Sold | 100,849 | 97,435 | 93,194 | 87,924 | 85,277 | 99,875 | 89,273 | 87,228 |
| Gross Profit | 70,322 | 85,670 | 98,646 | 86,490 | 85,251 | 86,648 | 101,941 | 95,166 |
| Operating Expenses | ||||||||
| Research & Development | 26,737 | 23,314 | 22,354 | 20,080 | 20,096 | 18,142 | 21,077 | 17,652 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 56,692 | 50,064 | 73,326 | 44,306 | 47,958 | 41,504 | 44,893 | 39,949 |
| Operating Income (Loss) | 13,630 | 35,606 | 25,320 | 42,184 | 37,293 | 45,144 | 57,048 | 55,217 |
| Interest Income | 2,400 | 2,423 | 2,246 | 1,921 | 2,089 | 2,292 | 2,427 | 3,337 |
| Interest Expense | ||||||||
| Other Expense | 575.00 | 515.00 | 231.00 | 1,511 | (2,234) | 2,951 | (5,094) | 298.00 |
| Pretax Income | 10,052 | 31,914 | 21,513 | 39,335 | 30,862 | 43,962 | 47,683 | 50,243 |
| Tax Provision | 3,632 | 7,485 | 4,163 | 8,305 | 5,577 | 5,998 | 7,254 | 12,294 |
| Net Income (Loss) | 6,420 | 24,429 | 17,350 | 31,030 | 25,285 | 37,964 | 40,429 | 37,949 |
| Earnings Per Share (Basic) | 0.14 | 0.52 | 0.38 | 0.66 | 0.53 | 0.78 | 0.83 | 0.77 |
| Earnings Per Share (Diluted) | 0.14 | 0.51 | 0.37 | 0.64 | 0.51 | 0.73 | 0.78 | 0.73 |
| Weighted Average Shares Outstanding (Basic) | 45,322 | 46,743 | 46,474 | 46,949 | 47,641 | 48,429 | 48,621 | 48,907 |
| Weighted Average Shares Outstanding (Diluted) | 46,458 | 48,215 | 47,677 | 48,128 | 49,890 | 52,058 | 51,862 | 52,046 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AMPH
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a stock listed on the Nasdaq Stock Market under the ticker symbol AMPH. It last traded at $25.14 (Oct 23, 2026, 4:00 PM ET), down 3.5% on the day. That gives Amphastar Pharmaceuticals a market capitalisation of $1.1B and a price-to-earnings ratio of 14.1.
Over the past 52 weeks AMPH has traded between $16.65 and $29.52.
Revenue for the quarter ended Mar 31, 2026 was $171.2M; net income $6.4M. Revenue was up 0.4% from $170.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $171.2M | $6.4M | 3.8% |
| Dec 31, 2025 | $183.1M | $24.4M | 13.3% |
| Sep 30, 2025 | $191.8M | $17.4M | 9.0% |
| Jun 30, 2025 | $174.4M | $31.0M | 17.8% |
From Amphastar Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…